RNA-based Therapeutics
The Future of RNA Therapeutics, From Design to Delivery
AIRNA nets $155M series B to launch clinical test of RNA editing tech
MultiOmic Health and Alloy Therapeutics Collaborate to Discover and Develop Renal Tissue-Targeting Drugs
RNA Biotechs: Current State And Outlook
RNA editing biotech Airna adds $155M in funding
Nutcracker Therapeutics CEO Dr. Igor Khandros Retires as Company Continues Evolution as an RNA Therapeutics CRDMO
RNA Analysis: Global Market Size, Shares, Trends, Opportunities and Forecast 2020-2030
Remix Therapeutics to Present at Stifel 2025 Virtual Targeted Oncology Forum
RNA Nanotechnology
Nature-inspired nanotechnology acts as body's own courier service for genetic medicines
RNA origami: Artificial cytoskeletons to build synthetic cells
RNA origami technique folds nanotubes to create artificial cytoskeletons for synthetic cells
Tiny exosome couriers rewrite the healing code — RNA delivery sparks a new era in ischemic disease treatment
New method uses DNA barcodes for high throughput RNA and protein detection in deep tissue
News on nanotechnology
Magnetic Tweezers: A Powerful Tool for Manipulating Biomolecules at the Nanoscale
RNA origami: Artificial cytoskeletons to build synthetic cells (w/video)
RNA Vaccines
Scientists unveil breakthrough in nano-delivery technology for DNA vaccines
Q&A: Nobel Prize-winning researcher and BU grad discusses vaccine development, vaccine hesitancy, and preparing for another pandemic
The Future of RNA Therapeutics, From Design to Delivery
Breakthrough mRNA vaccine reinvents pancreatic cancer treatment
An mRNA cancer vaccine may offer long-term protection
Beyond Black Box: How Data-Driven AI Is Transforming RNA Medicine Development
TechInvention Taps Belgian Expertise for mRNA Vaccine Revolution
A Wave of State Legislation Is Targeting mRNA Vaccines for Livestock
RFK Jr. paused this Peninsula company's half-billion-dollar vaccine contract, then it cut jobs
RNA
The battle between resilient plants and cunning viruses: Study discovers a novel RNA silencing mechanism
AIRNA nets $155M series B to launch clinical test of RNA editing tech
RNA editing biotech Airna adds $155M in funding
RNA interference and nanomedicine join forces to fight dangerous fungal infections
Exploring exosomal RNA as a biomarker for prostate cancer detection
AIRNA Hits $155M Series B Haul To Advance RNA Editor for Rare Genetic Disease
Flagship-backed Sail Biomedicines lays off staff following review of organizational structure
Computational platform helps unlock A20's dual role in cancer immunotherapy
Aqemia Advances Epitranscriptomics Programs and Expands into Small-Molecule RNA Targeting with $7.4 Million Grant
RNA Biotechs: Current State And Outlook
